目次

Table of Contents

1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive Landscape

2 Market Overview
2.1. Market definition
2.2. Market analysis

3 Market Data
3.1. Market value

4 Market Segmentation
4.1. Category segmentation
4.2. Geography segmentation

5 Market Outlook
5.1. Market value forecast

6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry

7 Competitive Landscape
7.1. Who are the leading players?
7.2. What strategies do leading players follow?
7.3. What has been the rationale behind recent M&A activity?
7.4. Do leading players have any notable weaknesses?

8 Company Profiles
8.1. Johnson & Johnson
8.2. AbbVie Inc.
8.3. Amgen, Inc.
8.4. Biogen, Inc.

9 Macroeconomic Indicators
9.1. Country data

10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine

List of Tables
Table 1: United States biotechnology industry value: $ billion, 2016-21
Table 2: United States biotechnology industry category segmentation: % share, by value, 2016-2021
Table 3: United States biotechnology industry category segmentation: $ billion, 2016-2021
Table 4: United States biotechnology industry geography segmentation: $ billion, 2021
Table 5: United States biotechnology industry value forecast: $ billion, 2021-26
Table 6: Johnson & Johnson: key facts
Table 7: Johnson & Johnson: Annual Financial Ratios
Table 8: Johnson & Johnson: Key Employees
Table 9: Johnson & Johnson: Key Employees Continued
Table 10: AbbVie Inc.: key facts
Table 11: AbbVie Inc.: Annual Financial Ratios
Table 12: AbbVie Inc.: Key Employees
Table 13: AbbVie Inc.: Key Employees Continued
Table 14: Amgen, Inc.: key facts
Table 15: Amgen, Inc.: Annual Financial Ratios
Table 16: Amgen, Inc.: Key Employees
Table 17: Amgen, Inc.: Key Employees Continued
Table 18: Biogen, Inc.: key facts
Table 19: Biogen, Inc.: Annual Financial Ratios
Table 20: Biogen, Inc.: Key Employees
Table 21: United States size of population (million), 2017-21
Table 22: United States gdp (constant 2005 prices, $ billion), 2017-21
Table 23: United States gdp (current prices, $ billion), 2017-21
Table 24: United States inflation, 2017-21
Table 25: United States consumer price index (absolute), 2017-21
Table 26: United States exchange rate, 2017-21

List of Figures
Figure 1: United States biotechnology industry value: $ billion, 2016-21
Figure 2: United States biotechnology industry category segmentation: $ billion, 2016-2021
Figure 3: United States biotechnology industry geography segmentation: % share, by value, 2021
Figure 4: United States biotechnology industry value forecast: $ billion, 2021-26
Figure 5: Forces driving competition in the biotechnology industry in the United States, 2021
Figure 6: Drivers of buyer power in the biotechnology industry in the United States, 2021
Figure 7: Drivers of supplier power in the biotechnology industry in the United States, 2021
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in the United States, 2021
Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in the United States, 2021
Figure 10: Drivers of degree of rivalry in the biotechnology industry in the United States, 2021